← The Wire
CYRXNasdaq
Cryoport, Inc.
Pharmaceutical Preparations · NV · CIK 1124524
Cryoport provides integrated, temperature-controlled supply chain solutions for life sciences, focusing on cell and gene therapies
$737M
Market cap
$16.28
Last close
+1.8%
1D
+10.2%
5D
965K
Volume
Price · last 39 sessions+59.5%
May 4L $10.21 · H $16.50Jun 29
358
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
S-1/AS-1/AAug 8, 2016S-1/AS-1/AMay 11, 2016S-1/AS-1/AMay 11, 2016S-1/AFORM S-1AJul 23, 2015S-1/AS-1/AJun 22, 2015S-1/AS-1/AJun 12, 2015S-1/AS-1/AMay 26, 2015S-1/AS-1/AApr 17, 2015S-1/AAMENDMENT NO. 4 TO FORM S-1Jun 21, 2012S-1/AAMENDMENT NO. 3 TO FORM S-1Jun 18, 2012S-1/AAMENDMENT NO. 2 TO FORM S-1May 18, 2012S-1/AAMENDMENT NO. 1 TO FORM S-1Apr 27, 2012S-1/AS-1/AApr 22, 2011S-1/AFORM S-1/ADec 28, 2010S-1/AFORM S-1/ADec 17, 2010S-1/AAMENDMENT NO. 8 TO FORM S-1 FOR CRYOPORT, INC.Feb 25, 2010S-1/AAMENDMENT NO. 7 TO FORM S-1 FOR CRYOPORT, INC.Feb 22, 2010S-1/AAMENDMENT NO. 6 TO FORM S-1 FOR CRYOPORT, INC.Feb 11, 2010S-1/AAMENDMENT NO. 5 TO FORM S-1Feb 9, 2010S-1/AFORM S-1 AMENDMENT NO. 4Feb 2, 2010S-1/AFORM S-1 AMENDMENTJan 22, 2010S-1/ACRYOPORT S1-A2Jan 14, 2010S-1/ACRYPORT, INC. AMENDMENT NO. 1 TO FORM S-1Jan 12, 2010S-1/ACRYOPORTAug 26, 2008S-1/AFORM S-1 AMENDMENTAug 15, 2008
Insider Activity
In the 90 days to Mar 23, 2026: 4 sold $471K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Shelton JerrellPresident, CEO | Sell | 2,894 | $8.18 | $24K |
| Mar 23, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 1,341 | $8.18 | $11K |
| Mar 23, 2026 | Stefanovich RobertChief Financial Officer | Sell | 1,094 | $8.18 | $9K |
| Mar 16, 2026 | Shelton JerrellPresident, CEO | Sell | 7,918 | $8.00 | $63K |
| Mar 16, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 3,235 | $8.00 | $26K |
| Mar 16, 2026 | Stefanovich RobertChief Financial Officer | Sell | 2,743 | $8.00 | $22K |
| Mar 16, 2026 | Zecchini Edward JSee Remarks | Sell | 2,014 | $8.00 | $16K |
| Mar 12, 2026 | Stefanovich RobertChief Financial Officer | Sell | 38,700 | $7.76 | $300K |
| Dec 10, 2025 | Mandalam RamkumarDirector | Sell | 11,570 | $9.99 | $116K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance